Current Studies for Type 2 Diabetes
Therapy: Oral Medication without Insulin

   

Volunteers Diagnosed with Diabetes are Needed


Profil® Institute for Clinical Research is conducting a clinical research study to evaluate the performance of an investigational device in people diagnosed with Diabetes.

In order to qualify you must be:

  • Diagnosed with either Type 1 or Type 2 Diabetes
  • Between 18 and 75 years old
  • Treating your condition with Insulin or Oral Anti-Diabetic medication

If you qualify you may be compensated up to $1,468.75 for time and travel.
6 out patient visits will be required but no overnights. 

For more information, call Profil® Institute today +1 (877) 487-2053.

or fill out online contact form.

See our Ad here.

 
 

ARE YOU CURRENTLY TAKING METFORMIN OR GLUCOPHAGE® ALONE?


Profil® Institute is conducting a clinical research study to evaluate an investigational oral drug in people diagnosed with Type 2 Diabetes.

In order to qualify you must be:

  • Between 18 and 75 years old
  • Diagnosed with Type 2 Diabetes
  • Treating your condition with Glucophage® or metformin alone

If you qualify and enter into the study you may be compensated up to $5,784.00 for time and travel.
A total of 22 overnights will be required. 

For more information, call Profil® Institute today +1 (866) 245-8171.

or fill out online contact form.

See our Ad here.

 

Back to Current Studies List
 

English (United States)   |   Español (México)


Study Volunteers 
  
  
  

click to find out more
 
         Current Studies         

 

 

Press Releases

      

 

Meet Profil Institute @

Profil Institute will attend the following scientific conferences.
 

 

Profil Institute in the Community


read more

 


read more

 


 

 

Current Job Openings

Interested in Career Opportunities at Profil Institute? 

 

Profil Institute Brochures

The Clinical Research Institute for Diabetes and Obesity

Unique Combination of Science and Clinical Competence

Future Diabetes Treatment Begins with You

El Tratamiento Futuro De La Diabetes Comienza con Usted